Bardoxolone methyl
RTA 402-C-1602
Phase 3 small_molecule terminated
Quick answer
Bardoxolone methyl for Pulmonary Hypertension is a Phase 3 program (small_molecule) at Biogen with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biogen
- Indication
- Pulmonary Hypertension
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated